3M CO
MMM · CIK 0000066740 · NYSE · Healthcare (Surgical & Medical Instruments & Apparatus)
Overview — 3M CO
Revenue (TTM)
$25.25B
Net Income (TTM)
$3.58B
Total Assets
$39.53B
Total Debt
$12.56B
Pros
- Strong return on equity (TTM)
Cons
- High debt relative to equity
- Revenue has declined over the last 5 years
Chart
No price data yet — run npm run ingest:prices in apps/api.
Revenue & Net Income
RevenueNet Income
Peers
Sector: Healthcare. Sector is derived from SEC's SIC code, not GICS. Click a column to sort.
| Company | Market Cap ▼ | Revenue (TTM) | Net Income (TTM) | Net Margin | ROE | Debt/Equity |
|---|---|---|---|---|---|---|
| JNJ JOHNSON & JOHNSON | $660.42B | $99.33B | $16.09B | 16.2% | 19.7% | 0.44 |
| ABBV AbbVie Inc. | $510.35B | $64.39B | $6.32B | 9.8% | -106.4% | — |
| MRK Merck & Co., Inc. | $362.01B | $66.57B | $3.17B | 4.8% | 7.6% | 1.28 |
| PFE PFIZER INC | $169.02B | $63.70B | $4.36B | 6.8% | 5.1% | 0.71 |
| MMM 3M CO | — | $25.25B | $3.58B | 14.2% | 85.9% | 3.01 |
Quarterly results
| Line item | Sep 23 | Dec 23 | Mar 24 | Jun 24 | Sep 24 | Dec 24 | Mar 25 | Jun 25 | Sep 25 | Mar 26 | Jun 26 | Sep 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.31B | $6.00B | $8.00B | $6.25B | $6.29B | $6.01B | $5.95B | $6.34B | $6.52B | $6.03B | $6.50B | $6.58B |
| Net Income | -$2.08B | $945.00M | $933.00M | $1.15B | $1.38B | $728.00M | $1.12B | $725.00M | $841.00M | $659.00M | $938.00M | $1.41B |
| Operating Cash Flow | — | — | $767.00M | — | — | — | -$79.00M | — | — | $574.00M | — | — |
Profit & Loss
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $30.11B | $31.66B | $32.77B | $32.14B | $32.18B | $35.35B | $34.23B | $32.68B | $24.57B | $24.95B | $25.25B |
| Net Income | $5.06B | $4.87B | $5.36B | $4.58B | $5.45B | $5.93B | $5.79B | -$7.00B | $4.19B | $3.26B | $3.58B |
Balance Sheet
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | — | — | — | — | — | $47.07B | $46.45B | — | — | $37.73B | $39.53B |
| Total Liabilities | — | — | — | — | — | $31.95B | $31.68B | — | — | $32.99B | $34.39B |
| Total Equity | — | — | — | — | — | $15.12B | $14.77B | — | — | $4.75B | $4.17B |
| Total Debt | — | — | — | — | — | $16.06B | $14.00B | — | — | $10.93B | $12.56B |
| Shares Outstanding | — | — | — | — | — | 571,100,000 | 550,500,000 | — | — | 526,700,000 | 516,729,574 |
Cash Flow
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6.66B | $6.24B | $6.44B | $7.07B | $8.11B | $7.45B | $5.59B | $6.68B | $1.82B | $2.31B | $2.96B |
| Capex | $1.42B | $1.37B | $1.58B | $1.70B | $1.50B | $1.60B | $1.75B | $1.61B | $1.18B | $910.00M | $899.00M |
Ratios
Profitability
| Ratio | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net margin | 16.8% | 15.4% | 16.4% | 14.3% | 16.9% | 16.8% | 16.9% | -21.4% | 17.0% | 13.1% | 14.2% |
| Return on equity | — | — | — | — | — | 39.2% | 39.2% | — | — | 68.7% | 85.9% |
| Return on assets | — | — | — | — | — | 12.6% | 12.5% | — | — | 8.6% | 9.1% |
| Return on capital employed (ROCE) | — | — | — | — | — | 19.4% | 17.7% | — | — | 16.5% | 17.1% |
| Debt / Equity | — | — | — | — | — | 1.06 | 0.95 | — | — | 2.30 | 3.01 |
| FCF margin | 17.4% | 15.4% | 14.8% | 16.7% | 20.5% | 16.5% | 11.2% | 15.5% | 2.6% | 5.6% | 8.2% |
Working capital
| Ratio | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | — | — | — | — | — | 48d | 48d | — | — | 52d | 60d |
| Inventory days | — | — | — | — | — | 97d | 102d | — | — | 89d | 98d |
| Payable days | — | — | — | — | — | 58d | 60d | — | — | 66d | 73d |
| Cash conversion cycle | — | — | — | — | — | 87d | 90d | — | — | 75d | 84d |
| Working capital days | — | — | — | — | — | 66d | 55d | — | — | 99d | 70d |
Investors
US filings have no equivalent to India's Promoter/FII/DII shareholding-pattern disclosure. Shown below are the closest real US sources: Form 4 insider transactions and Form 13F institutional holders (matched by issuer name, not CUSIP — a few companies, especially ones that changed their legal name, may be incomplete).
Institutional Holders
No data yet — run npm run ingest:institutions in apps/api.
Insider Trades
| Person | Relationship | Date | Type | Shares | Price |
|---|---|---|---|---|---|
| Rhodes Kevin H | EVP, Chief Legal Off & Secret | 10/7/2026 | Option exercise | 176 | $162.12 |
| Rhodes Kevin H | EVP, Chief Legal Off & Secret | 10/7/2026 | Tax withholding | 176 | $162.12 |
| Kshirsagar Tushar A. | EVP Chief Tech Officer | 10/7/2026 | Option exercise | 53 | $162.12 |
| Kshirsagar Tushar A. | EVP Chief Tech Officer | 10/7/2026 | Tax withholding | 53 | $162.12 |
| Goralski Christian T JR | Group President | 10/7/2026 | Option exercise | 1,288 | $162.12 |
| Goralski Christian T JR | Group President | 10/7/2026 | Option exercise | 219 | $162.12 |
| Goralski Christian T JR | Group President | 10/7/2026 | Option exercise | 217 | $162.12 |
| Goralski Christian T JR | Group President | 10/7/2026 | Tax withholding | 1,724 | $162.12 |
| Maheshwari Anurag | EVP & Chief Financial Officer | 10/1/2026 | Option exercise | 10,944 | $163.02 |
| Maheshwari Anurag | EVP & Chief Financial Officer | 10/1/2026 | Tax withholding | 4,991 | $163.02 |
| Chavez Rodriguez Beatriz Karina | Group President | 8/5/2026 | Sale | 3,635 | $182.51 |
| Reinseth Theresa E | Sr Vice President & CAO | 7/23/2026 | Sale | 924 | $169.42 |
| Banovetz John Patrick | Executive Vice President | 7/23/2026 | Option exercise | 7,880 | $154.69 |
| Banovetz John Patrick | Executive Vice President | 7/23/2026 | Sale | 7,880 | $170.44 |
| Rhodes Kevin H | EVP, Chief Legal Off & Secret | 7/22/2026 | Option exercise | 7,669 | $154.69 |
| Rhodes Kevin H | EVP, Chief Legal Off & Secret | 7/22/2026 | Sale | 7,669 | $171.20 |
| Goralski Christian T JR | Group President | 7/22/2026 | Option exercise | 4,902 | $154.69 |
| Goralski Christian T JR | Group President | 7/22/2026 | Sale | 4,902 | $170.46 |
| Bauer Wendy A | Group President | 7/1/2026 | Option exercise | 7,952 | $159.96 |
| Bauer Wendy A | Group President | 7/1/2026 | Tax withholding | 3,558 | $159.96 |
| RUMSEY JENNIFER | Director | 6/5/2026 | Grant/Award | 1,195.997 | $152.77 |
| Sweet Thomas W | Director | 5/12/2026 | Grant/Award | 1,360.402 | $143.34 |
| Kereere Suzan | Director | 5/12/2026 | Grant/Award | 1,360.402 | $143.34 |
| Chow Anne H | Director | 5/12/2026 | Grant/Award | 1,360.402 | $143.34 |
| BROWN THOMAS K | Director | 5/12/2026 | Grant/Award | 1,360.402 | $143.34 |
| Fitterling James R | Director | 5/12/2026 | Grant/Award | 1,360.402 | $143.34 |
| Bozeman David P | Director | 5/12/2026 | Grant/Award | 1,360.402 | $143.34 |
| Choi Audrey | Director | 5/12/2026 | Grant/Award | 1,360.402 | $143.34 |
Documents
- 10-Q — filed 10/20/20260000066740-26-000311
- 10-Q — filed 7/21/20260000066740-26-000246
- 10-Q — filed 4/21/20260000066740-26-000175
- 10-K — filed 2/3/20260000066740-26-000014
- 10-Q — filed 10/21/20250000066740-25-000089
- 10-Q — filed 7/18/20250000066740-25-000063
- 10-Q — filed 4/22/20250000066740-25-000039
- 10-K — filed 2/5/20250000066740-25-000006
- 10-Q — filed 10/22/20240000066740-24-000101
- 10-Q — filed 7/26/20240000066740-24-000080
- 10-Q — filed 4/30/20240000066740-24-000053
- 10-K — filed 2/7/20240000066740-24-000016
- 10-Q — filed 10/24/20230000066740-23-000092
- 10-Q — filed 7/25/20230000066740-23-000058
- 10-Q — filed 4/25/20230000066740-23-000028
- 10-K — filed 2/8/20230000066740-23-000014
- 10-Q — filed 10/25/20220000066740-22-000076
- 10-Q — filed 7/27/20220000066740-22-000065
- 10-Q — filed 4/26/20220000066740-22-000036
- 10-K — filed 2/9/20220000066740-22-000010
- 10-Q — filed 10/26/20210000066740-21-000013
- 10-Q — filed 7/27/20210001558370-21-009338
- 10-Q — filed 4/27/20210001558370-21-004896
- 10-K — filed 2/4/20210001558370-21-000737
- 10-Q — filed 10/27/20200001558370-20-011804
- 10-Q — filed 7/28/20200001558370-20-008507
- 10-Q — filed 4/28/20200001558370-20-004478
- 10-K — filed 2/6/20200001558370-20-000581
- 10-Q — filed 10/25/20190001558370-19-009143
- 10-Q — filed 7/26/20190001558370-19-006397
- 10-Q — filed 4/26/20190001558370-19-003408
- 10-K — filed 2/7/20190001558370-19-000470
- 10-Q — filed 10/25/20180001558370-18-007892
- 10-Q — filed 7/26/20180001558370-18-005773
- 10-Q — filed 5/8/20180001558370-18-004248
- 10-K — filed 2/8/20180001558370-18-000535
- 10-Q — filed 10/31/20170001558370-17-007801
- 10-Q — filed 8/1/20170001558370-17-005582
- 10-Q — filed 5/3/20170001558370-17-003391
- 10-K — filed 2/9/20170001558370-17-000479
- 10-Q — filed 11/1/20160001558370-16-008937
- 10-Q — filed 8/2/20160001558370-16-007105
- 10-Q — filed 5/3/20160001558370-16-005213
- 10-K — filed 2/11/20160001558370-16-003162
- 10-Q — filed 10/29/20150001558370-15-002024
- 10-Q — filed 7/30/20150001104659-15-054810
- 10-Q — filed 4/30/20150001104659-15-032226
- 10-K — filed 2/12/20150001104659-15-009560
- 10-Q — filed 10/30/20140001104659-14-075312
- 10-Q — filed 7/31/20140001104659-14-055558
- 10-Q — filed 5/1/20140001104659-14-033499
- 10-K — filed 2/13/20140001104659-14-009773
- 10-Q — filed 10/31/20130001104659-13-079583
- 10-Q — filed 8/1/20130001104659-13-058961
- 10-Q — filed 5/2/20130001104659-13-036580
- 10-K — filed 2/14/20130001104659-13-010881
- 10-Q — filed 11/1/20120001104659-12-073165
- 10-Q — filed 8/2/20120001104659-12-053732
- 10-Q — filed 5/3/20120001104659-12-032441
- 10-K — filed 2/16/20120001104659-12-010566
- 10-Q — filed 11/3/20110001104659-11-060552
- 10-Q — filed 8/4/20110001104659-11-043748
- 10-Q — filed 5/5/20110001104659-11-026236
- 10-K — filed 2/16/20110001104659-11-007845
- 10-Q — filed 11/5/20100001104659-10-056482
- 10-Q — filed 8/4/20100001104659-10-041912
- 10-Q — filed 5/5/20100001104659-10-025776
- 10-K — filed 2/16/20100001104659-10-007295
- 10-Q — filed 10/30/20090001104659-09-061503
- 10-Q — filed 7/31/20090001104659-09-046329